• SENSEX 78,806.82
    1,505.42 (+1.95%)
  • BANKNIFTY 55,913.60
    373.55 (+0.67%)
  • NSE
    1,845.00 1,878.00(%)
  • Lenskart Solut.
    767.40 725.00(%)
  • HDFC Bank
    762.80 1,017.90(%)
  • Reliance Industries
    1,306.65 1,152.30(%)
  • Bajaj Finance
    1,049.65 1,177.60(%)
  • Jio Platforms
    1,442.00 1,490.00(%)
  • Maruti Suzuki
    12,599.60 17,371.60(%)
  • CG Power & Ind
    812.95 525.50(%)
  • Paras Healthcare
    769.80 794.75(%)
  • NHPC Ltd
    83.49 86.86(%)
  • Ather Energy
    1,742.10 582.35(%)
  • Ashok Leyland
    169.40 215.35(%)
  • Saregama India
    628.10 305.65(%)
  • Tata Motors
    437.45 508.95(%)
  • P I Industries
    1,830.90 2,006.00(%)
  • Cummins India
    4,036.95 3,883.30(%)
  • Cholaman.Inv.&Fn
    1,763.15 1,952.00(%)
  • Multi Comm. Exc.
    3,361.00 3,537.00(%)
  • Exide Inds.
    378.75 496.00(%)
  • N S D L
    785.00 1,180.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Remus Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 78788.0
  • ISIN : INE0O5T01011
819.55 -26 (-3.09%)
  • As on 05 Nov 2026 (EOD)

  • Today’s Low

    810.00

  • Today’s High

    852.00

  • Open

    840.05

  • Perv Close

    845.65

  • 52W Low

    580.00

  • 52W High

    1,039.00

Key Indicators

  • P/E(TTM)

    40.04

  • Mar.Cap (₹Cr.)

    965.76

  • Div & Yield %

    0.06

  • Book Value(₹)

    276.40

  • Debt-Equity Ratio

    -3.09

  • AGM Date

    04-Nov-2026

  • EPS

    20.47

  • P/E Ratio

    40.04

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    965.76

  • RONW (%)

    15.40

  • ROCE (%)

    17.79

Score Board

  • Equity (₹ in Cr.)

    11.78

  • BV (₹)

    276.40

  • Sales( ₹ in Cr.)

    93.99

  • NP (in Cr.)

    24.12

  • NP Var(%)

    23.0

  • Div%

    5.0

  • CPS (₹)

    22.80

  • EPS (₹)

    20.50

  • Traded Value (₹ in Lakhs)

    965.76

  • 52 Week High

    1,039.00

  • 52 Week Low

    580.00

  • Price BSE

    0.0

  • Price NSE

    820.00

  • Market Capital( in Cr.)

    965.76

  • P/C Ratio

    36.00

  • P/E Ratio

    40.10

  • Price Vs.BV

    20.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 93.99 79.16 63.94 45.03 24.72 18.42
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 93.99 79.16 63.94 45.03 24.72 18.42
Other Income 6.84 2.91 2.81 1.58 0.72 0.81
Stock Adjustments 0.63 0.23 1.53 -1.30 0.44 0.71
Total Income 101.46 82.30 68.28 45.31 25.88 19.94
EXPENDITURE :            
Raw Materials 41.29 35.27 29.21 20.14 12.71 12.21
Power and Fuel Cost 0.03 0.04 0.00 0.00 0.00 0.00
Employee Cost 8.54 9.17 6.51 5.47 3.42 2.95
Other Manufacturing Expenses 6.19 3.73 4.05 4.57 2.02 0.00
Selling and Administration Expenses 8.37 4.89 4.45 2.98 2.70 0.00
Miscellaneous Expenses 0.48 0.31 0.25 0.02 0.17 3.17
Employee Benefit Expenses 8.54 9.17 6.51 5.47 3.42 2.95
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 64.90 53.41 44.47 33.18 21.02 18.33
Operating Profit 36.56 28.89 23.81 12.12 4.86 1.61
Interest 0.58 0.38 0.34 0.23 0.09 0.03
Gross Profit 35.98 28.51 23.47 11.89 4.77 1.58
Depreciation 2.75 1.87 1.12 0.48 0.15 0.18
Profit Before Tax 33.23 26.64 22.35 11.41 4.62 1.40
Current Tax 8.65 6.67 6.41 3.00 1.19 0.37
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.13 0.07 -0.68 -0.09 -0.01 -0.02
Reported Net Profit 24.71 19.90 16.62 8.50 3.43 1.06
Extraordinary Items 0.59 0.25 0.00 0.00 0.01 0.08
Adjusted Net Profit 24.12 19.65 16.62 8.50 3.42 0.98
Adjustment below Net Profit -5.89 -4.44 0.00 -0.20 -0.99 0.00
P & L Balance brought forward 44.09 29.81 13.78 5.58 3.13 2.07
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.18 1.18 0.59 0.00 0.00 0.00
P & L Balance carried down 61.73 44.09 29.81 13.89 5.58 3.13
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 5.00 15.00 60.00 20.00 0.00 0.00
Dividend Per Share(Rs) 0.50 1.50 6.00 2.00 0.00 0.00
Earnings Per Share-Unit Curr 20.98 33.79 113.06 78.37 34.34 1,059.50
Earnings Per Share(Adj)-Unit Curr 20.98 16.90 14.13 - - -
Book Value 276.49 411.24 1,044.56 176.36 65.78 3,143.70
Book Value(Adj)-Unit Curr 276.49 205.62 130.57 - - -

Shareholding Pattern

  • Promoter Group

    70.95%

  • Public Share Holding

    29.05%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 108,500 0.92 108,500 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,252,700 70.03 8,252,700 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,361,200 70.95 8,361,200 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 600,500 5.10 600,500 5
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 50,300 0.43 50,300 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 650,800 5.52 650,800 7
2] Non Institution
Bodies Corporate 159,200 1.35 159,200 43
Clearing Members 18,700 0.16 18,700 4
Directors of their Relatives 16,000 0.14 16,000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 27,800 0.24 27,800 58
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 310,500 2.63 310,500 147
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 803,000 6.81 803,000 15
Individuals holding nominal share capital up to Rs. 1 lakh 1,364,600 11.58 1,364,600 1,803
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,772,000 23.52 2,772,000 2,074
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,784,000 100.00 11,784,000 2,092

Company Background

Remus Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Remus Pharmaceuticals Ltd
  • BSE Code : 78788.0
  • ISIN : INE0O5T01011

  • Incorporation Year

    2015

  • Registered Office

    1101 to 1103 South Tower One42
    B/H Ashok Vatika Amblibopal Rd, Ahmedabad,
    Gujarat-380054

  • Telephone

    91-079-29999857

  • FAX

  • Chairman

    SWAPNIL JATINBHAI SHAH

  • Managing Director

    ARPIT DEEPAKKUMAR SHAH

  • Company Secretary

    Deval Patel

  • Auditor

    Pankaj R Shah & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Remus Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Remus Pharma. 819.55 100.83 93.99 39.08 11.66
Abbott India 27,146.85 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,365.10 2,304.07 2,275.58 93.81 27.86
Glaxosmi. Pharma 2,532.60 3,932.76 3,790.20 40.46 58.17
Evonile Pharma 1,736.60 393.10 354.33 43.85 15.94
Cipla 1,400.10 20,102.60 18,979.95 42.67 13.88
Bliss GVS Pharma 625.60 773.53 729.81 40.78 12.51
Amrutanjan Healt 511.45 520.13 502.55 27.39 24.16
Fermenta Biotec. 439.00 474.15 450.25 20.49 18.77
Guj. Themis Bio. 387.70 168.25 165.82 103.66 18.05
Ambalal Sarabhai 35.67 19.52 3.94 66.06 6.77